LGVN on Nasdaq

Longeveron Inc.

American pharmaceutical preparations company based in Miami.

Price unavailable

Last updated Oct 18, 2026.

Overview

$1.2MRevenue, fiscal 20252
-$22.7MNet income, fiscal 20252

Compare with ALX ONCOLOGY HOLDINGS INC, Bioline Rx Ltd. or Neuphoria Therapeutics Inc., or pick any stock.

  • TickerLGVN on Nasdaq
  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE3
  • Business address1951 Nw 7Th Avenue, Suite 520, Miami, Fl 331363
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

67.0%Gross margin2
-1942.2%Operating margin2
-1893.6%Net margin2
-49.9%Revenue growth, 20252
-400.1%Return on equity2
-$18.9MFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Clinical Trial Revenue brought in 80% of the revenue Longeveron Inc. broke down this way in fiscal 2025.

  1. Clinical Trial Revenue$954.0K280%down 32% from 2024
  2. Contract manufacturing revenues$222.0K219%down 54% from 2024
  3. Contract Manufacturing Lease Revenue$23.0K22%down 95% from 2024
Products and services by year
Products and services20242025
Clinical Trial Revenue$1.4M$954.0K
Contract manufacturing revenues$487.0K$222.0K
Contract Manufacturing Lease Revenue$503.0K$23.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue3¢$396.0K
  • Research and development97¢$12.0M

Out of $1.2M in revenue.2 The company lost money this year.

Financial statements

Revenue45672$1.2M in 2025−79% since 2020
0$2.0M$4.0M$6.0M2020: $5.6M$5.6M20202021: $1.3M$1.3M2021−77%2022: $1.2M$1.2M2022−6%2023: $709.0K$709.0K2023−42%2024: $2.4M$2.4M2024+237%2025: $1.2M$1.2M2025−50%
Gross profit45672$803.0K in 2025−56% since 2020
0$500.0K$1.0M$1.5M$2.0M2020: $1.8M$1.8M20202021: $590.0K$590.0K2021−68%2022: $497.0K$497.0K2022−16%2023: $221.0K$221.0K2023−56%2024: $1.9M$1.9M2024+752%2025: $803.0K$803.0K2025−57%
Operating income45672-$23.3M in 2025+516% since 2020
-$30.0M-$20.0M-$10.0M02020: -$3.8M-$3.8M20202021: -$17.5M-$17.5M2021+362%2022: -$18.0M-$18.0M2022+3%2023: -$21.0M-$21.0M2023+17%2024: -$16.5M-$16.5M2024−21%2025: -$23.3M-$23.3M2025+41%
Net income45672-$22.7M in 2025+510% since 2020
-$30.0M-$20.0M-$10.0M02020: -$3.7M-$3.7M20202021: -$17.0M-$17.0M2021+358%2022: -$18.8M-$18.8M2022+11%2023: -$21.4M-$21.4M2023+14%2024: -$16.0M-$16.0M2024−25%2025: -$22.7M-$22.7M2025+42%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-12-312024-12-31
Total revenues$1.2M$2.4M
Cost of revenues$396.0K$508.0K
Gross profit$803.0K$1.9M
General and administrative$12.0M$10.3M
Research and development$12.0M$8.1M
Total operating expenses$24.1M$18.4M
Loss from operations-$23.3M-$16.5M
Loss on disposal of assets-$97.0K
Other income (expense), net$680.0K$549.0K
Total other income (expenses), net$583.0K$549.0K
Net loss-$22.7M-$16.0M
Deemed dividend - warrant inducement offers$0-$8.7M
Net loss attributable to common stockholders-$22.7M-$24.6M
Basic net loss per share-$1.29-$2.62
Diluted net loss per share-$1.29-$2.62
Basic weighted average common shares outstanding17.6B shares9.4B shares
Diluted weighted average common shares outstanding17.6B shares9.4B shares

Compare Longeveron Inc. with another company

Leadership

Who has led Longeveron Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Geoff Green2021–2022
  2. Mohamed Wa'El Ahmed Hashad2023–2026
  3. Stephen H. Willard2026–now

Chair

  1. Joshua Hare2021

Chief financial officer

  1. James Clavijo2021–2023
  2. Lisa Locklear2023–2026
  3. Marie Washburn2026
  4. Nirav S. Jhaveri2026–now
2025
Board members and other officers (20)

Former names

  • LONGEVERON LLCNov 6, 2017 to Feb 10, 20213

Timeline

  1. Mar 13, 2026New chief executive Stephen H. Willard becomes CEO12
  2. Mar 2, 2023New chief executive Mohamed Wa'El Ahmed Hashad becomes CEO13
  3. Feb 11, 2021New chief executive Geoff Green becomes CEO14

Filings

451 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 85 major events, 217 insider forms, 14 large holders, 7 private raises, 107 other. The latest 20:

  1. Oct 14, 20268-K CURRENT REPORT EDGAR
  2. Oct 5, 20264 PRIMARY DOCUMENT EDGAR
  3. Oct 5, 20264 PRIMARY DOCUMENT EDGAR
  4. Oct 5, 20264 PRIMARY DOCUMENT EDGAR
  5. Oct 5, 20264 PRIMARY DOCUMENT EDGAR
  6. Oct 5, 20264 PRIMARY DOCUMENT EDGAR
  7. Sep 23, 20268-K CURRENT REPORT EDGAR
  8. Sep 14, 20268-K CURRENT REPORT EDGAR
  9. Sep 10, 2026SCHEDULE 13G EDGAR
  10. Aug 25, 20264 PRIMARY DOCUMENT EDGAR
  11. Aug 25, 20263 PRIMARY DOCUMENT EDGAR
  12. Aug 24, 20268-K CURRENT REPORT EDGAR
  13. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  14. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  15. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  16. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  17. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  18. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  19. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
  20. Aug 21, 20264 PRIMARY DOCUMENT EDGAR

The 451 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 14 such filings since October 2021, the latest 10:

  1. Sep 10, 2026SCHEDULE 13G
  2. Aug 13, 2026SCHEDULE 13G/A
  3. Aug 10, 2026SCHEDULE 13G
  4. May 15, 2026SCHEDULE 13G
  5. Feb 10, 2026SCHEDULE 13G/A
  6. Aug 27, 2025SCHEDULE 13G
  7. Aug 15, 2025SCHEDULE 13G
  8. Nov 14, 2024SC 13G/A
  9. Jul 26, 2024SC 13G
  10. Apr 17, 2024SC 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Mar 11, 2026Raised $15.9 million in a private offering of equity Form D: $33.5 million offered in all Form D
  2. Jul 19, 2024Filed a private offering of securities Form D: $9.5 million offered in all Form D
  3. Jun 18, 2024Filed a private offering of securities Form D: $9.4 million offered in all Form D
  4. Apr 18, 2024Filed a private offering of securities Form D: $12.4 million offered in all Form D
  5. Dec 22, 2023Filed a private offering of securities Form D: $2.6 million offered in all Form D
  6. Oct 13, 2023Filed a private offering of securities Form D: $8.4 million offered in all Form D
  7. Dec 3, 2021Raised $20.5 million in a private offering of equity Form D: 20 investors so far Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38